Daud, Shaira I.
HRN: 28-21-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2025
CEFUROXIME 750MG (VIAL)
12/06/2025
12/13/2025
IV
630mg
Q8hours
PCAP-B
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes